ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,701.70
0.96%
S&P ASX All Technology
3,075.00
0.84%
Brent Oil
81.295
0.00%
US Dollar vs AUD
1.49858
0.00%
Bitcoin
67,570.55
-0.23%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pluri Inc (PLUR)

  7. Pluri Inc (PLUR) News

PLUR

Pluri (PLUR)

Pluri Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PLUR
DateTimeSourceHeadlineSymbolCompany
01/06/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLURPluri Inc
20/05/202421:00GlobeNewswire Inc.Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial ScaleNASDAQ:PLURPluri Inc
10/05/202406:13Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PLURPluri Inc
10/05/202406:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PLURPluri Inc
10/05/202406:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLURPluri Inc
02/05/202421:00GlobeNewswire Inc.Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer TreatmentNASDAQ:PLURPluri Inc
08/04/202421:00GlobeNewswire Inc.Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New MethodNASDAQ:PLURPluri Inc
28/03/202422:15GlobeNewswire Inc.Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming ConferencesNASDAQ:PLURPluri Inc
27/03/202422:00GlobeNewswire Inc.Pluri Inc. Announces 1-for-8 Reverse Share SplitNASDAQ:PLURPluri Inc
21/03/202422:00GlobeNewswire Inc.Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market ReportNASDAQ:PLURPluri Inc
19/03/202419:00GlobeNewswire Inc.Engage with Pluri's Talent: Exciting Conference Appearances AheadNASDAQ:PLURPluri Inc
14/03/202422:00GlobeNewswire Inc.Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug ManufacturingNASDAQ:PLURPluri Inc
11/03/202422:00GlobeNewswire Inc.Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell CultivationNASDAQ:PLURPluri Inc
06/03/202423:00GlobeNewswire Inc.Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory BoardNASDAQ:PLURPluri Inc
28/02/202423:00GlobeNewswire Inc.Pluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 GoalsNASDAQ:PLURPluri Inc
15/02/202409:43Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PLURPluri Inc
14/02/202408:34Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PLURPluri Inc
13/02/202408:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLURPluri Inc
02/02/202408:02Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PLURPluri Inc
26/01/202408:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLURPluri Inc
26/01/202408:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLURPluri Inc
26/01/202408:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLURPluri Inc
26/01/202408:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLURPluri Inc
26/01/202408:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLURPluri Inc
26/01/202408:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLURPluri Inc
26/01/202408:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLURPluri Inc
24/01/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLURPluri Inc
23/01/202418:00GlobeNewswire Inc.Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee CrisisNASDAQ:PLURPluri Inc
09/01/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLURPluri Inc
21/12/202323:00GlobeNewswire Inc.Pluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine AddictionNASDAQ:PLURPluri Inc
 Showing the most relevant articles for your search:NASDAQ:PLUR

Your Recent History

PM
XAUUSD
Gold vs US Dollar
ASX
CSL
CSL
ASX
TLS
Telstra
NASDAQ
TSLA
Tesla
SPI
SP500
S&P 500
ASX
WES
Wesfarmers
ASX
WPL
Woodside Petroleum
NYSE
NKE
Nike
NASDAQ
NVDA
NVIDIA
ASX
XAO
Australian SE All Ordina...
CCOM
SILVER
SILVER
NYSE
VZ
Verizon Communications
FTSE
UKX
FTSE 100
NYSE
DIS
Walt Disney
ASX
XTO
S&P ASX 100
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved